extends: existence
message: "Required PK/PD element missing: %s"
level: error
tokens:
  # PK Parameters - Basic
  - absorption rate constant (ka, h⁻¹)
  - volume of distribution (Vd, L or L/kg)
  - clearance (CL, L/h or mL/min)
  - bioavailability (F, %)
  - terminal half-life (t1/2, h)
  - accumulation ratio (Rac, unitless)
  - time to steady state (Tss, days)
  - dose proportionality (slope, 90% CI)
  - peak concentration (Cmax, ng/mL)
  - time to peak (Tmax, h)
  - area under curve (AUC0-t, AUC0-inf, ng·h/mL)
  - elimination rate constant (ke, h⁻¹)
  - mean residence time (MRT, h)
  - distribution phases (α, β, h⁻¹)

  # PK Parameters - Advanced
  - apparent volume (V/F, L)
  - apparent clearance (CL/F, L/h)
  - bioequivalence metrics (90% CI)
  - food effect (GMR, 90% CI)
  - drug-drug interactions (AUCR, CmaxR)
  - metabolite profiling (% parent)
  - mass balance recovery (% dose)
  - protein binding (fu, %)
  - blood-to-plasma ratio (B/P ratio)
  - tissue distribution (Kp values)
  - enterohepatic circulation (AUC ratio)
  - flip-flop kinetics (ka/ke ratio)
  - non-linear pharmacokinetics (dose vs AUC)

  # Population PK Parameters
  - between-subject variability (CV%)
  - covariate effects (% change)
  - residual error (additive, proportional)
  - shrinkage estimates (η, ε)
  - condition number (κ)
  - correlation matrix (r values)
  - random effects distribution
  - allometric scaling exponents

  # PD Parameters
  - Emax (units per endpoint)
  - EC50 (ng/mL)
  - Hill coefficient (n)
  - effect delay (keO, h⁻¹)
  - baseline effect (E0)
  - placebo response
  - tolerance development (k)
  - rebound magnitude

  # PK/PD Relationships
  - exposure-response slope
  - therapeutic window
  - safety margins
  - target engagement (%)
  - receptor occupancy
  - temporal relationships
  - effect compartment (Ce)
  - hysteresis assessment

  # Population PK
  - between-subject variability
  - covariate effects
  - residual error model
  - shrinkage estimates
  - eta-shrinkage
  - epsilon-shrinkage
  - condition number
  - correlation matrix
  - omega matrices
  - random effects distribution
  - interoccasion variability
  - allometric scaling

  # PD Modeling
  - exposure-response relationship
  - effect compartment model
  - tolerance development
  - hysteresis assessment
  - Emax model parameters
  - EC50 estimation
  - baseline effect
  - effect delay
  - sigmoid Emax model
  - competitive antagonism
  - partial agonism
  - receptor desensitization

  # Joint PK/PD
  - linking functions
  - turnover models
  - indirect response models
  - receptor occupancy
  - target-mediated disposition
  - competitive binding
  - signal transduction
  - homeostatic feedback
  - transit compartments
  - effect compartment link
  - physiological adaptation
  - tolerance mechanisms
